Posted by Michael Wonder on 29 Aug 2021
Breakthrough PBS listings to benefit thousands of Australians
29 August 2021 - From 1 September 2021, thousands of Australians living with schizophrenia, liver disease, lymphoma and anaphylaxis will have access to new treatments through new and amended listings on the Pharmaceutical Benefits Scheme.
For the first time, Australians with schizophrenia will have access to the antipsychotic Reagila (cariprazine).
